Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
COVID-19 Vaccine AstraZeneca effective against Delta (‘Indian’) variant
-
Update on AZD7442 STORM CHASER trial in post-exposure prevention of symptomatic COVID-19
-
Calquence demonstrated fewer incidences of atrial fibrillation versus ibrutinib in previously treated patients with chronic lymphocytic leukaemia and sustained patient benefit at four years in the front-line setting
-
AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
-
Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years
-
Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial
-
Anifrolumab showed benefit across different measures of skin and joint disease activity in patients with systemic lupus erythematosus
-
Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
-
AstraZeneca ASCO 2021 data support ambition to revolutionise cancer outcomes by treating earlier and transforming the patient experience
Latest articles and press releases
All of our latest press releases and articles are available to explore
